Stock Events

Stock Events

Chromocell Therapeutics (CHRO) Q3 2024 Earnings

13AugConfirmed

Q1 1

Q2 2024

Q3 2024

-2.9

-2.04

-1.17

-0.31

Details

Expected EPS

-0.31

Actual EPS

-0.31

Surprise EPS

0

Surprise Percent

+0%

Description

Chromocell Therapeutics (CHRO) has reported earnings of -0.31 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.